![]() |
Volumn 9, Issue 1, 2010, Pages 14-17
|
Neurological infections: the year of PML and influenza
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EFALIZUMAB;
INFLUENZA VACCINE;
MEFLOQUINE;
NATALIZUMAB;
OSELTAMIVIR;
PROTEIN MAD1;
RITUXIMAB;
ARTICLE;
COGNITIVE DEFECT;
CROHN DISEASE;
DISEASE ASSOCIATION;
DRUG EFFICACY;
ERYTHROPHAGOCYTOSIS;
GUILLAIN BARRE SYNDROME;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFLUENZA;
INFLUENZA VIRUS A H1N1;
INFLUENZA VIRUS A H5N1;
JC VIRUS;
MULTIPLE SCLEROSIS;
NEUROLOGICAL COMPLICATION;
PRE B LYMPHOCYTE;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
REYE SYNDROME;
RISK FACTOR;
SEIZURE;
SEQUENCE ANALYSIS;
VIRUS LOAD;
VIRUS STRAIN;
|
EID: 72149083046
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(09)70337-0 Document Type: Note |
Times cited : (11)
|
References (9)
|